This inventor holds 17 USPTO granted patents, primarily in Biopharmaceutical Development. Top assignees: Hoechst Aktiengesellschaft, Heochst Aktiengesellschaft. Active years: 1985-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Eppstein, DE (1985 - 1997)
- Eppstein/Taunus, DE (1992 - 1997)
- Eppstein am Taunus, DE (1994 - 1997)
Company Filing History:
Years Active: 1985-1997
Areas of Expertise:
Title: The Innovations of Dominique Tripier: A Pioneer in Pharmaceutical Patents
Introduction: Dominique Tripier, based in Eppstein/Taunus, Germany, is a remarkable inventor recognized for his significant contributions to the field of pharmaceuticals. With a total of 17 patents to his name, his work has had a profound impact, particularly in the development of medicinal compounds with anticoagulatory effects and treatments for diabetes mellitus.
Latest Patents: Two of Tripier's latest patents highlight his innovative approach to pharmaceutical science. The first is focused on hirudin derivatives, which can be prepared through the selective enzymatic replacement of part of the molecule with an amino derivative. These hirudin derivatives are designed for the preparation of pharmaceuticals that possess anticoagulatory effects. The second patent involves phosphoinositol-glycan-peptides with insulin-like action. These peptides are derived by cleaving adenosine 3',5'-cyclic monophosphate-binding protein and include essential components such as glucosamine, galactose, mannose, inositol, phosphoric acid, ethanolamine, and a peptide with the sequence Asx-Cys-Tyr. This invention aims at providing treatment options for diabetes mellitus and non-insulin-dependent diabetes.
Career Highlights: Throughout his career, Dominique Tripier has contributed significantly to the pharmaceutical industry by working with prominent companies. Notably, he has been associated with Hoechst Aktiengesellschaft, where he has honed his expertise and innovated in the field of pharmaceutical development.
Collaborations: In his professional journey, Tripier has collaborated with notable individuals such as Paul Habermann and Peter Crause. These partnerships have played a critical role in advancing his research and patent applications.
Conclusion: Dominique Tripier stands out as an influential inventor whose work continues to push the boundaries of pharmaceutical innovation. With a strong emphasis on developing compounds that improve health outcomes, his patented inventions reflect his dedication to enhancing treatments for conditions such as diabetes and anticoagulation therapy. His legacy as a pioneer in pharmaceuticals serves as an inspiration for future inventors in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile